Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What have we learned about lipids and cardiovascular risk from PCSK9 inhibitor outcome trials: ODYSSEY and FOURIER?

× No keyword cloud information.

16 in total

1. PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021.

Authors: Maciej Banach; Paweł Burchardt; Krzysztof Chlebus; Piotr Dobrowolski; Dariusz Dudek; Krzysztof Dyrbuś; Mariusz Gąsior; Piotr Jankowski; Jacek Jóźwiak; Longina Kłosiewicz-Latoszek; Irina Kowalska; Maciej Małecki; Aleksander Prejbisz; Michał Rakowski; Jacek Rysz; Bogdan Solnica; Dariusz Sitkiewicz; Grażyna Sygitowicz; Grażyna Sypniewska; Tomasz Tomasik; Adam Windak; Dorota Zozulińska-Ziółkiewicz; Barbara Cybulska
Journal: Arch Med Sci Date: 2021-11-08 Impact factor: 3.318

Review 2. The role of inflammation and the possibilities of inflammation reduction to prevent cardiovascular events.

Authors: Serban Maierean; Richard Webb; Maciej Banach; Mohsen Mazidi
Journal: Eur Heart J Open Date: 2022-06-14

Review 3. Clinical approach to the inflammatory etiology of cardiovascular diseases.

Authors: Massimiliano Ruscica; Alberto Corsini; Nicola Ferri; Maciej Banach; Cesare R Sirtori
Journal: Pharmacol Res Date: 2020-05-20 Impact factor: 7.658

4. Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer.

Authors: Amir Abbas Momtazi-Borojeni; Maryam Ebrahimi Nik; Mahmoud Reza Jaafari; Maciej Banach; Amirhossein Sahebkar
Journal: Arch Med Sci Date: 2019-04-30 Impact factor: 3.318

5. Effects of immunization against PCSK9 in an experimental model of breast cancer.

Authors: Amir Abbas Momtazi-Borojeni; Maryam Ebrahimi Nik; Mahmoud Reza Jaafari; Maciej Banach; Amirhossein Sahebkar
Journal: Arch Med Sci Date: 2019-04-30 Impact factor: 3.318

6. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic.

Authors: Maciej Banach; Peter E Penson; Zlatko Fras; Michal Vrablik; Daniel Pella; Željko Reiner; Seyed Mohammad Nabavi; Amirhossein Sahebkar; Meral Kayikcioglu; Magdalena Daccord
Journal: Pharmacol Res Date: 2020-05-07 Impact factor: 7.658

Review 7. Effects of PCSK9 Targeting: Alleviating Oxidation, Inflammation, and Atherosclerosis.

Authors: Emily Punch; Justus Klein; Patrick Diaba-Nuhoho; Henning Morawietz; Mahdi Garelnabi
Journal: J Am Heart Assoc Date: 2022-01-20 Impact factor: 6.106

8. Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic.

Authors: Niki Katsiki; Maciej Banach; Dimitri P Mikhailidis
Journal: Arch Med Sci Date: 2020-04-14 Impact factor: 3.318

Review 9. Cardiovascular diseases, lipid-lowering therapies and European registries in the COVID-19 pandemic.

Authors: Henning Morawietz; Ulrich Julius; Stefan R Bornstein
Journal: Cardiovasc Res Date: 2020-08-01 Impact factor: 10.787

Review 10. Pulse wave velocity as a measure of arterial stiffness in patients with familial hypercholesterolemia: a systematic review and meta-analysis.

Authors: Željko Reiner; Luis E Simental-Mendía; Massimiliano Ruscica; Niki Katsiki; Maciej Banach; Khalid Al Rasadi; Tannaz Jamialahmadi; Amirhossein Sahebkar
Journal: Arch Med Sci Date: 2019-11-03 Impact factor: 3.318